CellProthera-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:CellProthera - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013153
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
CellProthera (CellProthera) focuses on the development of therapeutic solutions for the regeneration of organs which are damaged by disease or trauma from autologous blood peripheral stem cells. The company’s lead candidate ProtheraCytes, is an advanced therapy medicinal product within tissue engineered products. CellProthera primarily focuses on the utilization of blood peripheral stem cells for cardiac diseases. It is developing a therapeutic solution concept of functional regeneration of the damaged heart muscle after myocardial infarction (AMI). The company works in partnership with other organizations such as Institut de Recherche en Hematologie et Transplantation (IRHT) and Pierre and Marie Curie (UPCM) to enhance its research and developments. CellProthera is headquartered in Mulhouse Cedex, France.

CellProthera – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
CellProthera, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CellProthera, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CellProthera, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CellProthera, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
CellProthera, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CellProthera, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
CellProthera Raises USD8.7 Million in Financing 10
CellProthera Raises US$3.4 Million In Venture Financing 11
CellProthera Raises US$3.2 Million In Venture Financing 12
CellProthera – Key Competitors 13
CellProthera – Key Employees 14
CellProthera – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 16
Corporate Communications 16
Dec 07, 2016: New governance at CellProthera 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
CellProthera, Pharmaceuticals & Healthcare, Key Facts 2
CellProthera, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
CellProthera, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
CellProthera, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
CellProthera, Deals By Therapy Area, 2011 to YTD 2017 8
CellProthera, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
CellProthera Raises USD8.7 Million in Financing 10
CellProthera Raises US$3.4 Million In Venture Financing 11
CellProthera Raises US$3.2 Million In Venture Financing 12
CellProthera, Key Competitors 13
CellProthera, Key Employees 14
CellProthera, Other Locations 15

★海外企業調査レポート[CellProthera-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Danaher Corp (DHR):医療機器:M&Aディール及び事業提携情報
    Summary Danaher Corp (Danaher) is a medical technology company which designs, manufactures and markets medical, professional, commercial and industrial products and services. It offers a wide range of testing instruments, communications solutions, water quality systems, medical diagnostics solutions …
  • Genting Bhd (GENTING):企業の財務・戦略的SWOT分析
    Genting Bhd (GENTING) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • TVA Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary TVA Medical Inc (TVA Medical) is a medical device company that designs and manufactures catheter-based systems. The company offers minimally invasive therapies for treatment of end stage renal disease. It offers everlinq, an endovascular device used for creating an AV fistula for hemodialysi …
  • Olam International Ltd:企業のM&A・事業提携・投資動向
    Olam International Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Olam International Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • ImpediMed Ltd (IPD):企業の財務・戦略的SWOT分析
    ImpediMed Ltd (IPD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Concord New Energy Group Ltd (182):企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Costco Wholesale UK Limited:企業の戦略・SWOT・財務分析
    Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report Summary Costco Wholesale UK Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Kyushu Financial Group Inc (7180):企業の財務・戦略的SWOT分析
    Kyushu Financial Group Inc (7180) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Santos Ltd (STO):石油・ガス:M&Aディール及び事業提携情報
    Summary Santos Ltd (Santos) is an independent oil and natural gas company. Its activities include onshore, offshore and liquefied natural gas (LNG) projects. The company has exploration and production acreage in Australia and Papua New Guinea. Its core natural gas assets include Cooper Basin, Queens …
  • Eni SpA (ENI):企業の財務・戦略的SWOT分析
    Eni SpA (ENI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Domino’s Pizza, Inc.:企業の戦略・SWOT・財務情報
    Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report Summary Domino's Pizza, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • MemorialCare Health System:製薬・医療:M&Aディール及び事業提携情報
    Summary MemorialCare Health System (MemorialCare) is a non-profit health system that offers medical services. The center offers care services such as stroke care, cancer care, rehabilitation and physical therapy, weight-loss surgery, heart and vascular care, breast care, imaging and radiology, labor …
  • Japan Pulp and Paper Company Limited:企業の戦略・SWOT・財務情報
    Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report Summary Japan Pulp and Paper Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • ATUM-製薬・医療分野:企業M&A・提携分析
    Summary ATUM, formerly DNA2.0 Inc is a bioengineering company that provide platforms for protein and vector engineering solutions. The company develops and offers synthetic biology solutions. Its products include expression vectors, electra system, CRISPR/Cas9, proteinpaintbox, cell strains and reag …
  • Bureau Veritas SA (BVI):電力:M&Aディール及び事業提携情報
    Summary Bureau Veritas SA (Bureau Veritas) is a provider of testing, inspection and certification services. The company offers asset management, certification, consulting, inspection and audits, testing and analysis, and training. It serves aeronautics, agriculture, automotive, construction and real …
  • Meridian Bancorp Inc (EBSB):企業の財務・戦略的SWOT分析
    Meridian Bancorp Inc (EBSB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • British American Tobacco p.l.c.:戦略・SWOT・企業財務分析
    British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report Summary British American Tobacco p.l.c. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Moldex-Metric Inc:企業の戦略的SWOT分析
    Moldex-Metric Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • vTv Therapeutics Inc (VTVT):企業の財務・戦略的SWOT分析
    Summary vTv Therapeutics Inc (vTv), formerly TransTech Inc, is a pharmaceutical company that discovers, develops and commercializes human therapeutics. The company offers a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases includ …
  • North European Oil Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    North European Oil Royalty Trust Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary North European Oil Royalty Trust (NEORT) is an oil and gas trust that holds overriding royalty rights covering gas and oil production in concessions or leases. The trust holds royalty ri …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆